Skip to main content

Advertisement

Table 1 Primary and secondary outcomes of patients with enterococcal BSI

From: Disposition of linezolid or daptomycin in Enterococcal bloodstream infections according to vancomycin resistant Enterococcus colonization

  Non-colonized VRE-colonized p-value
n = 51 n = 50
Primary outcomes  
Empiric linezolid or daptomycin (n, %) 8 (15.6) 27 (54) <0.01
Could be de-escalated (n, %) 3 (37.5) 4 (14.8) 0.31
De-escalated (n, %) 2 (66.7) 2 (50) 0.09
Secondary outcomes  
VRE BSI (n, %) 11 (21.5) 42 (84) <0.01
E. faecium (n, %) 17 (33.3) 42 (84) <0.01
Neutropenia (n, %) 3 (5.9) 16 (32) <0.01
Transplant (n, %) 7 (13.7) 19 (38) <0.01
Sepsis (n, %) 19 (37.2) 27 (54) 0.09
Mortality (n, %) 10 (19.6) 11 (22) 0.78